Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost savings compared to CRP alone The $9.95 Million Question: Is ESR Worth Keeping? A ...
ALCOR Scientific reports a study indicating that combining ESR and CRP tests may reduce misdiagnoses and save hospitals nearly $10 million annually.
The $9.95 Million Question: Is ESR Worth Keeping? Combining ESR with CRP reduces misdiagnoses and generates substantial net cost savings compared to ordering CRP alone. A new ALCOR Scientific ...
The $9.95 Million Question: Is ESR Worth Keeping? A new ALCOR Scientific sponsored peer-reviewed study published in ClinicoEconomics and Outcomes Research makes a powerful economic case for retaining ...
A new ALCOR Scientific sponsored peer-reviewed study published in ClinicoEconomics and Outcomes Research makes a powerful economic case for retaining erythrocyte sedimentation rate (ESR) testing ...